Literature DB >> 30019967

Gastrointestinal pathophysiology and nutrition in cystic fibrosis.

Thomas L Ratchford1, Jeffrey H Teckman1, Dhiren R Patel1.   

Abstract

INTRODUCTION: Cystic fibrosis (CF) is a severe, progressive, multisystemic disease that is caused by mutations in the cystic fibrosis transmembrane conductance regulator gene. Optimizing nutrition is critical, as higher growth parameters are associated with better pulmonary function and outcomes, but unfortunately patients with this disease are prone to malnutrition, growth failure, and vitamin deficiencies. The purpose of this review is to provide a timely highlight of the physiologic processes and outcome data to support today's management strategies, as well as review these principles themselves. Areas covered: This review covers the background of the importance of vigilant attention to nutrition and growth in these patients, the underlying physiology leading to an abnormal gastrointestinal tract and its role in CF malnutrition, and current evaluation and management strategies to address nutrition in CF. Analysis of up-to-date relevant literature was performed using PubMed. Expert commentary: Advances in research and clinical developments over the years have improved knowledge of this disease as well as patient outcomes. Of particular importance is optimizing nutrition especially in the early stages of life, as well as accounting for the markedly abnormal CF intestinal milieu when addressing the gastrointestinal and nutritional needs of these patients.

Entities:  

Keywords:  Cystic fibrosis transmembrane conductance regulator (CFTR); Pancreatic enzyme replacement therapy (PERT); cystic fibrosis; enteral nutrition; failure to thrive; growth failure; malabsorption; nutrition; pancreatic insufficiency; vitamin deficiency

Mesh:

Substances:

Year:  2018        PMID: 30019967     DOI: 10.1080/17474124.2018.1502663

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  4 in total

1.  Evaluation of Malnutrition Risk in Lung Transplant Candidates Using the Nutritional Risk Index.

Authors:  Karan Chohan; Jeff Park; Sarah Dales; Rhea Varughese; Lisa Wickerson; Lianne G Singer; Brooke Stewart; Dmitry Rozenberg
Journal:  Transplant Direct       Date:  2020-06-23

2.  Assessment of the microbial load of airway clearance devices used by a cohort of children with cystic fibrosis.

Authors:  B Linnane; N H O'Connell; E Obande; S S Dunne; C Clancy; M G Kiernan; D McGrath; K J O'Sullivan; L O'Sullivan; C P Dunne
Journal:  Infect Prev Pract       Date:  2021-06-06

Review 3.  Understanding Cystic Fibrosis Comorbidities and Their Impact on Nutritional Management.

Authors:  Dhiren Patel; Albert Shan; Stacy Mathews; Meghana Sathe
Journal:  Nutrients       Date:  2022-02-28       Impact factor: 5.717

4.  Correlates of Pancreatic Enzyme Replacement Therapy Intake in Adults with Cystic Fibrosis: Results of a Cross-Sectional Study.

Authors:  Mette F Olsen; Maria S Kjøller-Svarre; Grith Møller; Terese L Katzenstein; Bibi U Nielsen; Tacjana Pressler; Jack I Lewis; Inger H Mathiesen; Christian Mølgaard; Daniel Faurholt-Jepsen
Journal:  Nutrients       Date:  2022-03-22       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.